Reference health

11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

https://doi.org/10.2139/ssrn.3571291
CiteStamped reference-health badge
58/58 checkable references clean · checked 2026-09-13

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 58 checked references that resolve
resolves10.1101/002824
HTSeq – A Python framework to work with high-throughput sequencing data
resolves10.1158/0008-5472.can-08-2819
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
resolves10.1111/febs.13148
Sp1 and the ‘hallmarks of cancer’
resolves10.1038/nrc1014
Neuroblastoma: biological insights into a clinical enigma
resolves10.1038/nrclinonc.2014.168
Mechanisms of neuroblastoma regression
resolves10.1042/bj20081834
High incidence of DNA mutations and gene amplifications of the <i>ALK</i> gene in advanced sporadic neuroblastoma tumours
resolves10.1073/pnas.0910684107
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
resolves10.1242/dmm.010348
Cell culture and <i>Drosophila</i> model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
resolves10.1136/jclinpath-2019-206063
The prognostic roles of and correlation between <i>ALK</i> and <i>MYCN</i> protein expression in neuroblastoma
resolves10.1186/1471-2164-5-70
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
resolves10.1016/j.neuro.2008.11.001
Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research
resolves10.1097/00001756-200310270-00011
Differential effects of 9-cis, 13-cis and all-trans retinoic acids on the neuronal differentiation of human neuroblastoma cells
resolves10.1073/pnas.1012351108
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
resolves10.1200/jco.1996.14.1.25
Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
resolves10.1158/1078-0432.ccr-09-2660
Meta-analysis of Neuroblastomas Reveals a Skewed <i>ALK</i> Mutation Spectrum in Tumors with <i>MYCN</i> Amplification
resolves10.1038/nrc.2017.103
Differentiation therapy revisited
resolves10.1126/scisignal.2005769
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
resolves10.1038/24179
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
resolves10.1038/nature25480
The landscape of genomic alterations across childhood cancers
resolves10.1101/mcs.a002550
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
resolves10.1038/sj.onc.1202887
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
resolves10.1101/gr.135350.111
GENCODE: The reference human genome annotation for The ENCODE Project
resolves10.18632/oncotarget.17146
Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma
resolves10.1038/onc.2011.568
Sp1 expression regulates lung tumor progression
resolves10.1016/j.autneu.2009.07.020
The development of the chromaffin cell lineage from the neural crest
resolves10.1101/gad.929901
<i>Dmp1</i> is haplo-insufficient for tumor suppression and modifies the frequencies of <i>Arf</i> and <i>p53</i> mutations in <i>Myc</i>-induced lymphomas
resolves10.3389/fnmol.2016.00156
Achaete-Scute Homolog 1 Expression Controls Cellular Differentiation of Neuroblastoma
resolves10.1038/sj.onc.1209111
Hint1 is a haplo-insufficient tumor suppressor in mice
resolves10.1093/database/bav095
RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse
resolves10.1186/s13059-014-0550-8
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
resolves10.1074/jbc.270.42.24725
Selective Regulation of TrkA and TrkB Receptors by Retinoic Acid and Interferon-γ in Human Neuroblastoma Cell Lines
resolves10.1056/nejmra0804577
Recent Advances in Neuroblastoma
resolves10.1002/1096-911x(20010101)36:1<24::aid-mpo1007>3.0.co;2-7
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma
resolves10.1016/s0140-6736(07)60983-0
Neuroblastoma
resolves10.1016/j.ajhg.2007.12.009
Structural Variation of Chromosomes in Autism Spectrum Disorder
resolves10.1007/s12325-012-0047-3
Retinoids in Pediatric Onco-Hematology: the Model of Acute Promyelocytic Leukemia and Neuroblastoma
resolves10.1200/jco.2007.13.8925
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-<i>cis</i>-Retinoic Acid: A Children's Oncology Group Study
resolves10.1056/nejm199910143411601
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-<i>cis</i>-Retinoic Acid
resolves10.1016/j.euprot.2017.06.001
Quantitative proteomic analysis identifies proteins and pathways related to neuronal development in differentiated SH-SY5Y neuroblastoma cells
resolves10.1016/j.jss.2014.07.018
Mesenchymal change and drug resistance in neuroblastoma
resolves10.1016/j.ccell.2014.09.014
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
resolves10.1002/pbc.24433
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
resolves10.1016/j.canlet.2015.09.010
Corrigendum to “The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro” [Cancer Lett 364 (2015) 142–155]
resolves10.1038/ng.2529
The genetic landscape of high-risk neuroblastoma
resolves10.1111/j.1742-4658.2012.08729.x
The <scp>PDZ</scp> protein discs‐large (<scp>DLG</scp>): the ‘<scp>J</scp>ekyll and <scp>H</scp>yde’ of the epithelial polarity proteins
resolves10.1210/en.2005-0467
Insulin-Like Growth Factor Binding Protein-2 Binding to Extracellular Matrix Plays a Critical Role in Neuroblastoma Cell Proliferation, Migration, and Invasion
resolves10.1126/science.1222369
The Dorsal Aorta Initiates a Molecular Cascade That Instructs Sympatho-Adrenal Specification
resolves10.1038/s41388-018-0444-4
Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma
resolves10.1002/mpo.10313
FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high‐risk groups in neuroblastoma
resolves10.1002/gcc.2870070106
Deletion of chromosome 11 and of 14q sequences in neuroblastoma
resolves10.1073/pnas.0506580102
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
resolves10.1086/383253
Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in Neuroblastoma
resolves10.1126/scisignal.aam7550
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas
resolves10.1038/ng.3899
Neuroblastoma is composed of two super-enhancer-associated differentiation states
resolves10.1007/s12253-015-9908-9
The Role of Id2 Protein in Neuroblatoma in Children
resolves10.1038/nmeth.1322
Universal sample preparation method for proteome analysis
resolves10.3389/fonc.2019.00275
Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
resolves10.1016/0092-8674(81)90009-x
The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions
The 3 references without a DOI — listed, not checked
no DOI — not checkedMultipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla
no DOI — not checkedA developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage
no DOI — not checkedAssociation of neurotrophin receptor expression and differentiation in human neuroblastoma
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-09-13 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.3571291"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3571291/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.3571291/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.3571291)